![]() | ZUCCOLI, E., Al Sawaf, H., Tuzza, M., Nickels, S. L., ZAGARE, A., & SCHWAMBORN, J. C. (17 October 2025). Reproducibility of PD patient-specific midbrain organoid data for in vitro disease modeling. iScience, 28 (10), 113541. doi:10.1016/j.isci.2025.113541 Peer Reviewed verified by ORBi |
![]() | CHEMLA, A., ARENA, G., SACRIPANTI, G., BARMPA, K., ZAGARE, A., GARCIA, P., GORGOGIETAS, V., ANTONY, P., OHNMACHT, J., BARON, A., Jung, J., Lind-Holm Mogensen, F., MICHELUCCI, A., MARZESCO, A.-M., BUTTINI, M., Schmidt, T., GRÜNEWALD, A., SCHWAMBORN, J. C., KRÜGER, R., & SARAIVA, C. (03 October 2025). Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss. Brain: a Journal of Neurology, 148 (10), 3607 - 3622. doi:10.1093/brain/awaf051 Peer Reviewed verified by ORBi |
![]() | GOMEZ GIRO, G., FRANGENBERG-HOFF, D., VEGA GUTIERREZ, D. M., ZAGARE, A., BARMPA, K., ANTONY, P., ROBERTSON, G., Sabahi-Kaviani, R., Haendler, K., Kruse, N., Papastefanaki, F., Matsas, R., Spielmann, M., Luttge, R., & SCHWAMBORN, J. C. (May 2025). α-Synuclein Pathology Spreads in a Midbrain-Hindbrain Assembloid Model. Advanced Science, 12 (20), 2409040. doi:10.1002/advs.202409040 Peer reviewed |
![]() | ZAGARE, A., SAUTER, T., BARMPA, K., PIRES PACHECO, M. I., KRÜGER, R., SCHWAMBORN, J. C., & SARAIVA, C. (17 April 2025). MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson's disease-associated dopaminergic neuron loss. NPJ Systems Biology and Applications, 11 (1), 37. doi:10.1038/s41540-025-00509-x Peer Reviewed verified by ORBi |
![]() | ZAGARE, A., BALAUR, I.-A., ROUGNY, A., SARAIVA, C., GOBIN, M., MONZEL, A. S., GHOSH, S., SATAGOPAM, V., & SCHWAMBORN, J. C. (31 March 2025). Deciphering shared molecular dysregulation across Parkinson's disease variants using a multi-modal network-based data integration and analysis. NPJ Parkinson's Disease, 11 (1), 63. doi:10.1038/s41531-025-00914-3 Peer Reviewed verified by ORBi |
![]() | ZAGARE, A., Kurlovics, J., ALMEIDA, C., FERRANTE, D., FRANGENBERG-HOFF, D., VITALI, A., GOMEZ GIRO, G., JÄGER, C., ANTONY, P., HALDER, R., KRÜGER, R., GLAAB, E., Stalidzans, E., ARENA, G., & SCHWAMBORN, J. C. (28 January 2025). Insulin resistance compromises midbrain organoid neuronal activity and metabolic efficiency predisposing to Parkinson's disease pathology. Journal of Tissue Engineering, 16, 20417314241295928. doi:10.1177/20417314241295928 Peer Reviewed verified by ORBi |
![]() | Mommaerts, K., Monzel, A. S., ZAGARE, A., NICKELS, S., DIEDERICH, N., LONGHINO, L., Mathieson, W., ANTONY, P., BETSOU, F., & SCHWAMBORN, J. C. (24 January 2025). Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson's Disease. Parkinson's Disease, 2025 (1), 5149071. doi:10.1155/padi/5149071 Peer Reviewed verified by ORBi |
![]() | ZAGARE, A., HEMEDAN, A., ALMEIDA, C., Frangenberg, D., Gomez-Giro, G., ANTONY, P., HALDER, R., Krüger, R., GLAAB, E., OSTASZEWSKI, M., ARENA, G., & SCHWAMBORN, J. C. (2024). Insulin Resistance Is a Modifying Factor for Parkinson's Disease. Movement Disorders. doi:10.1002/mds.30039 Peer Reviewed verified by ORBi |
![]() | ZAGARE, A., Preciat, G., NICKELS, S. L., Luo, X., MONZEL, A. S., Gomez-Giro, G., ROBERTSON, G., Jaeger, C., Sharif, J., Koseki, H., DIEDERICH, N., GLAAB, E., FLEMING, R. M., & SCHWAMBORN, J. C. (20 November 2023). Omics data integration suggests a potential idiopathic Parkinson's disease signature. Communications Biology, 6 (1), 1179. doi:10.1038/s42003-023-05548-w Peer Reviewed verified by ORBi |
![]() | ZAGARE, A. (2023). Contribution of Type 2 Diabetes and genetic variants in LRRK2 and GBA to Parkinson's disease [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/58118 |
![]() | ZAGARE, A., BARMPA, K., SMAJIC, S., SMITS, L., GRZYB, K., GRÜNEWALD, A., SKUPIN, A., NICKELS, S. L., & SCHWAMBORN, J. C. (2022). Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression. American Journal of Human Genetics. doi:10.1016/j.ajhg.2021.12.009 Peer Reviewed verified by ORBi |
![]() | ZAGARE, A., GOBIN, M., Monzel, A., & SCHWAMBORN, J. C. (2021). A robust protocol for the generation of human midbrain organoids. STAR Protocols. doi:10.1016/j.xpro.2021.100524 Peer Reviewed verified by ORBi |
![]() | MONZEL, A. S., Hemmer, K., SMITS, L., BOLOGNIN, S., Lucarelli, P., ROSETY, I., ZAGARE, A., ANTONY, P., Nickels, S., KRÜGER, R., & SCHWAMBORN, J. C. (2020). Machine learning-assisted neurotoxicity prediction in human midbrain organoids. Parkinsonism and Related Disorders. doi:10.1016/j.parkreldis.2020.05.011 Peer Reviewed verified by ORBi |
![]() | HEIRENDT, L., Arreckx, S., PFAU, T., Mendoza, S. N., Richelle, A., Heinken, A. K., Haraldsdottir, H. S., Wachowiak, J., Keating, S. M., VLASOV, V., Magnusdottir, S., Ng, C. Y., Preciat, G., ZAGARE, A., Chan, S. H. J., Aurich, M. K., Clancy, C. M., Modamio, J., Sauls, J. T., ... Fleming, R. M. T. (2019). Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0. Nature Protocols, 14 (3), 639-702. doi:10.1038/s41596-018-0098-2 Peer Reviewed verified by ORBi |
![]() | NORONHA, A., MODAMIO CHAMARRO, J., JAROSZ, Y., GUERARD, E., Sompairac, N., PRECIAT GONZALEZ, G. A., DANIELSDOTTIR, A. D., KRECKE, M., MERTEN, D., HARALDSDOTTIR, H., HEINKEN, A. K., HEIRENDT, L., MAGNUSDOTTIR, S., RAVCHEEV, D., SAHOO, S., GAWRON, P., FRISCIONI, L., GARCIA SANTA CRUZ, B., Prendergast, M., ... THIELE, I. (2018). The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease. Nucleic Acids Research. doi:10.1093/nar/gky992 Peer Reviewed verified by ORBi |